Goodrx Holdings Inc (GDRX) — Capital Reinvestment Ratio

Latest as of September 2025: 0.24x

Goodrx Holdings Inc (GDRX) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow ($76.02 Million) in capital expenditures ($18.00 Million). Check how tangible is Goodrx Holdings Inc's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

$76.02 Million
USD

Capital Expenditures

$18.00 Million
USD

Data as of

Sep 2025
Most recent filing

Goodrx Holdings Inc Capital Reinvestment Ratio (2018–2024)

This chart tracks Goodrx Holdings Inc's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see GDRX operating cash flow.

Annual Capital Reinvestment Ratio for Goodrx Holdings Inc (2018–2024)

Year-by-year Capital Reinvestment Ratio for Goodrx Holdings Inc from 2018 to 2024. See free cash flow generation of Goodrx Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.38x $183.89 Million $70.35 Million ▼ -5.1%
2023 0.40x $138.29 Million $55.77 Million ▲ +7.2%
2022 0.38x $146.78 Million $55.21 Million ▲ +95.2%
2021 0.19x $178.78 Million $34.46 Million ▼ -29.3%
2020 0.27x $131.34 Million $35.82 Million ▲ +295.1%
2019 0.07x $83.29 Million $5.75 Million ▼ -9.7%
2018 0.08x $45.25 Million $3.46 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow